Regeneron Pharmaceuticals (REGN.VI) Q2 2018 Earnings

3MayConfirmed
Q3 2017
Q4 2017
Q1 2018
Q2 2018
2.69
3.21
3.74
4.27

Details

Expected EPS
3.7021608
Actual EPS
3.8939394
Surprise EPS
0.19
Surprise Percent
+5.18%

Description

Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 3.8939394 per share for Q2 2018.

0 Comments

Share your thoughts